Patent directory · USPTO A61K / A61P
Patents matching “AUTOLUS LIMITED”
49 pharma patents match "AUTOLUS LIMITED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 49 pharmaceutical patents matching "AUTOLUS LIMITED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12398194
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface
granted -
US 12325733
Binding domain
granted -
US 12304942
Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor
granted -
US 12269860
Compositions and methods comprising engineered chimeric antigen receptor and modulator of CAR
granted -
US 12241068
CD79-specific chimeric antigen receptor
granted -
US 12234295
Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof
granted -
US 12187769
Cell
granted -
US 12049510
Chimeric antigen receptor
granted -
US 11982673
Methods
granted -
US 11982672
Methods
granted -
US 11963981
Chimeric antigen receptor
granted -
US 11959084
Nucleic acid construct
granted -
US 11903967
Method of preparing T cells with increased activity
granted -
US 11885807
Method for depleting malignant T-cells
granted -
US 11885806
Method for depleting malignant T-cells
granted -
US 11879016
Chimeric antigen receptor
granted -
US 11851672
CAR T-cells comprising transcriptional circuits
granted -
US 11814641
Retroviral and lentiviral vectors
granted -
US 11701386
Cell
granted -
US 11648274
Polypeptide
granted -
US 11643453
Cell
granted -
US 11613559
Nucleic acid construct
granted -
US 11591613
Retroviral and lentiviral vectors
granted -
US 11590170
Chimeric antigen receptor
granted